CRESCENT BIOPHARMA, INC.

financial.report · SEC EDGAR

This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.

Event type

financial.report

Occurred

2026-03-31

Reported

2026-04-29

Disclosure lag

29 days

Context

links are based on the recorded entity type

Field	Recorded value
Entity	CRESCENT BIOPHARMA, INC.
Source	SEC EDGAR ↗
Source identifier	companyfacts/CIK0001253689/2026-07-26
Event ID	#27528

Recorded payload

JSON payload as stored after parsing

{
  "accession": "0001628280-26-028362",
  "canonical_covered": 11,
  "canonical_total": 12,
  "fiscal_period": "Q1",
  "fiscal_year": 2026,
  "form": "10-Q",
  "mapped_tag_share": 0.05128205128205128,
  "metrics": {
    "cash_and_equivalents": 189163000,
    "net_income": -23283000,
    "operating_cash_flow": -8937000,
    "operating_income": -24729000,
    "revenue": 1039000,
    "shareholders_equity": 183847000,
    "shares_outstanding": 27571935,
    "total_assets": 199130000,
    "total_liabilities": 15283000
  },
  "metrics_reported": 9,
  "period_end": "2026-03-31"
}

Source: SEC EDGAR · as of 2026-04-29T00:00:00Z